BN Business News
Add your company to Business Communicator →

Business · 09/03/2007Updated: 10/17/2026 · 1 min read

FDA Approves Supplemental New Animal Drug Application for Enrofloxacin Injectable Solution

Summary

The FDA is updating its regulations to reflect the approval of a supplemental new animal drug application filed by Bayer HealthCare LLC, which allows for changes to the labeling of enrofloxacin injectable solution for treating bovine respiratory pathogens.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →